Blockchain Registration Transaction Record

HeartBeam Appoints Commercial Chief to Drive Cardiac Tech Expansion

HeartBeam appoints Bryan Humbarger as chief commercial officer to lead launch of FDA-cleared 3D ECG system for arrhythmia assessment and heart attack detection.

This development matters because it represents a significant step toward making advanced cardiac monitoring more accessible and portable, potentially transforming how heart conditions are detected and managed. Heart disease remains the leading cause of death globally, and traditional ECG monitoring often requires hospital visits, creating barriers to early detection. HeartBeam's cable-free 3D ECG technology could enable continuous, remote monitoring that catches arrhythmias and potential heart attacks earlier, when interventions are most effective. The appointment of an experienced commercial leader signals the company's readiness to bring this innovation to market, which could mean faster diagnosis, reduced hospitalizations, and improved outcomes for millions at risk of cardiac events. As healthcare increasingly shifts toward remote monitoring solutions, this technology addresses critical gaps in cardiac care accessibility.